Bogoljub Ciric, PhD

Bogoljub Ciric, PhD

Contact Dr.  Ciric

901 Walnut Street
Suite 400
Philadelphia, PA 19107

(215) 955-9425

Most Recent Peer-reviewed Publications

  1. Induction of peripheral tolerance in ongoing autoimmune inflammation requires interleukin 27 signaling in dendritic cells
  2. LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis
  3. 1,25-Dihydroxyvitamin D3suppressed experimental autoimmune encephalomyelitis through both immunomodulation and oligodendrocyte maturation
  4. Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair
  5. Selective depletion of CD11c+CD11b+dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE
  6. Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity
  7. Galectin-1 is essential for the induction of MOG35–55-based intravenous tolerance in experimental autoimmune encephalomyelitis
  8. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis
  9. IL-9 signaling affects central nervous system resident cells during inflammatory stimuli
  10. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway
  11. Emerging immunopharmacological targets in multiple sclerosis
  12. 1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation
  13. Granulocyte-macrophage colony-stimulating factor in central nervous system autoimmunity
  14. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity
  15. Expression of GM-CSF in T cells is increased in multiple sclerosis and suppressed by IFN-β therapy
  16. Astrocyte-derived lactosylceramide implicated in multiple sclerosis
  17. Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells
  18. Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells
  19. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis
  20. Committed Tc17 cells are phenotypically and functionally resistant to the effects of IL-27